Blue Gene technology, developed by IBM, focuses on designing supercomputers capable of petaflop speeds with low power consumption, primarily aimed at studying biomolecular phenomena. Its applications span scientific research, drug discovery, weather forecasting, computational biology, nuclear fusion, and material science. The technology has evolved through iterations Blue Gene/L, Blue Gene/P, and Blue Gene/Q, significantly contributing to high-performance computing while also facing challenges in power consumption and scalability.